{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-025512","form_type":"8-K","ticker":"TPB","cik":"0001290677","company_name":"Turning Point Brands, Inc.","filed_at":"2026-08-04T12:06:20+00:00","discovered_at":"2026-08-04T12:10:00.369635+00:00","generated_at":"2026-08-04T12:10:06.984656+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Turning Point Brands Q2 net sales up 22.6% to $142.9M; EPS falls to $0.18 from $0.79","bullets":["Modern Oral net sales up 128% to $68.4M, now 48% of total net sales (26% in Q2 2025).","Net income down 75.2% to $3.6M; adjusted diluted EPS $0.23 vs $0.98.","Stoker's segment net sales up 54.5% to $107.6M; Zig-Zag down 3.5% to $35.4M.","Raised FY2026 Modern Oral net sales guidance to $260-270M from $210-225M.","Adjusted EBITDA guidance $70-90M; SG&A up 91.1% to $76.9M on Modern Oral investments."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-025512","json":"https://secwatch.observer/filing/0001437749-26-025512.json","markdown":"https://secwatch.observer/filing/0001437749-26-025512.md","text":"https://secwatch.observer/filing/0001437749-26-025512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1290677/000143774926025512/0001437749-26-025512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1290677/000143774926025512/tpb20260528_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T12:10:06.984656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}